Recombinant factor VIIa for long-term replacement therapy in patients with congenital factor VII deficiency

Angela Huth-Kühne; Hannelore Rott; Rainer Zimmermann; Susan Halimeh

doi:10.1160/TH06-12-0729

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2007; 98(04): 912-915
DOI: 10.1160/TH06-12-0729

Letters to the Editor

Schattauer GmbH

Recombinant factor VIIa for long-term replacement therapy in patients with congenital factor VII deficiency

Authors

Angela Huth-Kühne

¹SRH Kurpfalzhospital and Hemophilia Center Heidelberg, Heidelberg, Germany
Hannelore Rott

²Group Practice for Laboratory and Transfusion Medicine Dr. med. H. Rott – Prof. Dr. med. H. Trobisch, Duisburg, Germany
Rainer Zimmermann

¹SRH Kurpfalzhospital and Hemophilia Center Heidelberg, Heidelberg, Germany
Susan Halimeh

²Group Practice for Laboratory and Transfusion Medicine Dr. med. H. Rott – Prof. Dr. med. H. Trobisch, Duisburg, Germany

Abstract

Full Text

References

References
1 Perry DJ. Factor VII deficiency.. Blood Coagul Fibrinolysis 2003; 14 (Suppl. 01) S47-54.
2 Rivard GE, Kovac I, Kunschak M. et al. Clinical study of recovery and half-life of vapor-heated factor VII concentrate.. Transfusion 1994; 34: 975-979.
3 Berrettini M, Mariani G, Schiavonni M. et al. Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency.. Haematologica 2001; 86: 640-645.
4 Ingerslev J, Christiansen K, Sorensen B. International Registry on Factor VII Deficiency (IRF7) Steering Committee.. Inhibitor to factor VII in severe factor VII deficiency: detection and course of the inhibitory response.. J Thromb Haemost 2005; 3: 799-800.
5 Mariani G, Herrmann FH, Dolce A. et al. for the International Factor VII Deficiency Study Group. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency.. Thromb Haemost 2005; 93: 481-487.
6 Giansily-Blaizot M, Schved JF. Potential predictors of bleeding risk in inherited factor VII deficiency. Clinical, biological and molecular criteria.. Thromb Haemost 2005; 94: 901-906.
7 Mariani G, Herrmann FN, Schulman S. et al. for the International Factor VII Deficiency Study Group. Thrombosis in inherited factor VII deficiency.. J Thromb Haemost 2003; 1: 2153-2158.
8 Schulman S, Tjonnfjord GE, Wallensten R. et al. Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII.. Thromb Haemost 2005; 94: 1177-1180.
9 Mariani G, Konkle BA, Ingerslev J. Congenital factor VII deficiency: therapy with recombinant activated factor VII – a critical appraisal.. Haemophilia 2006; 12: 19-27.
10 Soucie JM, Siwak EB, Hooper WC. et al. Human parvovirus B19 in young male patients with hemophilia A: associations with treatment product exposure and joint range-of-motion limitation.. Transfusion 2004; 44: 1179-1185.